223 related articles for article (PubMed ID: 34920121)
1. Blood Management Following Total Joint Arthroplasty in an Aging Population: Can We Do Better?
Hanreich C; Cushner F; Krell E; Gausden E; Cororaton A; Gonzalez Della Valle A; Boettner F
J Arthroplasty; 2022 Apr; 37(4):642-651. PubMed ID: 34920121
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Intravenous and Topical Tranexamic Acid in Total Joint Arthroplasty.
Masaryk J; Melus V; Vidan J; Steno B
Acta Chir Orthop Traumatol Cech; 2022; 89(4):286-292. PubMed ID: 36055669
[TBL] [Abstract][Full Text] [Related]
3. One Dose of Intravenous Tranexamic Acid Is Equivalent to Two Doses in Total Hip and Knee Arthroplasty.
Wilde JM; Copp SN; McCauley JC; Bugbee WD
J Bone Joint Surg Am; 2018 Jul; 100(13):1104-1109. PubMed ID: 29975264
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic Acid Benefits Total Joint Arthroplasty Patients Regardless of Preoperative Hemoglobin Value.
Whiting DR; Duncan CM; Sierra RJ; Smith HM
J Arthroplasty; 2015 Dec; 30(12):2098-101. PubMed ID: 26115982
[TBL] [Abstract][Full Text] [Related]
6. What Should Define Preoperative Anemia in Primary THA?
Klement MR; Peres-Da-Silva A; Nickel BT; Green CL; Wellman SS; Attarian DE; Bolognesi MP; Seyler TM
Clin Orthop Relat Res; 2017 Nov; 475(11):2683-2691. PubMed ID: 28786087
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: a randomised, non-inferiority trial.
DeFrancesco CJ; Reichel JF; Gbaje E; Popovic M; Freeman C; Wong M; DeMeo D; Liu J; Gonzalez Della Valle A; Ranawat A; Cross M; Sculco PK; Haskins S; Kim D; Maalouf D; Kirksey M; Jules-Elysee K; Soffin EM; Kumar K; Beathe J; Figgie M; Inglis A; Garvin S; Alexiades M; DelPizzo K; Russell LA; Sideris A; Saleh J; Zhong H; Memtsoudis SG
Br J Anaesth; 2023 Feb; 130(2):234-241. PubMed ID: 36526484
[TBL] [Abstract][Full Text] [Related]
8. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.
Huang ZY; Huang Q; Zeng HJ; Ma J; Shen B; Zhou ZK; Pei FX
BMC Musculoskelet Disord; 2019 Sep; 20(1):402. PubMed ID: 31481049
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of an optimized blood management program in total hip and knee arthroplasty: A large, single-center, retrospective study.
Zhang S; Huang Q; Xu B; Ma J; Cao G; Pei F
Medicine (Baltimore); 2018 Jan; 97(1):e9429. PubMed ID: 29505518
[TBL] [Abstract][Full Text] [Related]
11. Does the Use of Tranexamic Acid in Patients Who Have Preoperative Coagulopathy Undergoing Total Joint Arthroplasty Normalize Their Risk of Complications? A Matched Equivalence Analysis.
Meghpara MM; Goh GS; Ciesielka KA; Fillingham YA
J Arthroplasty; 2023 Nov; 38(11):2264-2268. PubMed ID: 37244426
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of Efficacy of Systemic Administration of Tranexamic Acid (Exacyl) in Total Hip and Knee Arthroplasty - Prospective Cohort Study].
Mannová J; Kubát P; Pospíchal M; Longin P
Acta Chir Orthop Traumatol Cech; 2019; 86(2):118-123. PubMed ID: 31070570
[TBL] [Abstract][Full Text] [Related]
13. Comparing Cost, Efficacy, and Safety of Intravenous and Topical Tranexamic Acid in Total Hip and Knee Arthroplasty.
DiBlasi JF; Smith RP; Garavaglia J; Quedado J; Frye BM; Dietz MJ
Am J Orthop (Belle Mead NJ); 2016; 45(7):E439-E443. PubMed ID: 28005108
[TBL] [Abstract][Full Text] [Related]
14. Low Risk of Thromboembolic Events After Routine Administration of Tranexamic Acid in Hip and Knee Arthroplasty.
Madsen RV; Nielsen CS; Kallemose T; Husted H; Troelsen A
J Arthroplasty; 2017 Apr; 32(4):1298-1303. PubMed ID: 27843042
[TBL] [Abstract][Full Text] [Related]
15. Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Konig G; Hamlin BR; Waters JH
J Arthroplasty; 2013 Oct; 28(9):1473-6. PubMed ID: 23886406
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic Acid Was Safe in Arthroplasty Patients With a History of Venous Thromboembolism: A Matched Outcome Study.
Sabbag OD; Abdel MP; Amundson AW; Larson DR; Pagnano MW
J Arthroplasty; 2017 Sep; 32(9S):S246-S250. PubMed ID: 28262452
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: An updated meta-analysis.
Xie J; Hu Q; Huang Q; Ma J; Lei Y; Pei F
Thromb Res; 2017 May; 153():28-36. PubMed ID: 28319822
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial on the effect of tranexamic acid on bleeding and fibrinolysis in primary hip and knee replacement.
Alvarez J; Santiveri FJ; Ramos MI; Gallart L; Aguilera L; Puig-Verdie L
Rev Esp Anestesiol Reanim (Engl Ed); 2019; 66(6):299-306. PubMed ID: 30902396
[TBL] [Abstract][Full Text] [Related]
19. Topical versus systemic tranexamic acid after total knee and hip arthroplasty: A meta-analysis of randomized controlled trials.
Chen Y; Chen Z; Cui S; Li Z; Yuan Z
Medicine (Baltimore); 2016 Oct; 95(41):e4656. PubMed ID: 27741100
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Effects of Intravenous and Oral Tranexamic Acid on Perioperative Hemoglobin Levels During Total Knee Arthroplasty.
Pathan S; Cruz JE; Curtin P
Ann Pharmacother; 2020 Feb; 54(2):138-143. PubMed ID: 31507212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
